Table 5.
Antithrombotic therapy | Group 2 - New onset AF |
---|---|
Aspirin + Clopidogrel + Vitamin K antagonists | 10.2 |
Aspirin + Clopidogrel + NOACs | 5.9 |
Aspirin + Ticagrelor/Prasugrel + Vitamin K antagonists | 0 |
Aspirin + Ticagrelor/Prasugrel + NOACs | 0 |
Total | 16.1 |
Values are percentage (%). AF: atrial fibrillation; ACE inhibitors: angiotensin conversion enzyme inhibitors; ARB: angiotensin receptor blockers; NOAC: non vitamin K anticoagulant.